N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine

Term ID

CHEBI:64098

Synonyms

(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane
(2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzodioxan
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
N-(2-(2,6-Dimethoxyphenoxy)ethyl)-2,3-dihydro-1,4-benzodioxin-2-methanamine
WB 4101
WB-4101
WB4101

Definition

A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An α1A-adrenergic selective antagonist.

References

lincs.smallmolecule:LSM-15338
pubmed:18850495
pubmed:19041301
pubmed:19114413
pubmed:19463264
pubmed:19686710
pubmed:20450248
pubmed:20554480
pubmed:20862454
pubmed:21146475
pubmed:21219971
pubmed:21475142
pubmed:21535246
pubmed:22179423
pubmed:7901775
reaxys:4206776

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine

Phenotype where environments contain N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine

Phenotype modified by environments containing N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine

Phenotype affecting N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine

Human Disease Model